课题基金 / 基金详情

PRIMARY PREVENTION TRIAL (DPT-2)

PRIMARY PREVENTION TRIAL (DPT-2)
一级预防试验 (DPT-2)
批准号:
6177184
负责人:
BOYD E METZGER
金额:
$66.38万
依托单位国家:
美国
项目类别:
财政年份:
1994
资助国家:
美国
项目状态:
已结题
起止时间:
1994-08-20 至 2003-06-30

项目摘要

项目成果

BOYD E METZGER的其他基金

相关文献

中文摘要
翻译
本建议书是根据RFA:DK-93-07“NIDDM”提交的 初级预防试验“NIDDM是#年的主要公共卫生问题 美国及其流行率高得不成比例 一些少数族裔群体,包括美洲原住民、西班牙裔和 非裔美国人,这些少数群体的成员,肥胖的对象, 一级亲属中有非胰岛素依赖型糖尿病家族史者 和所有种族的既往妊娠期糖尿病(GDM)患者 民族人群是NIDDM发病的高危人群。我们 已经制定了一项多中心研究的方案,以测试 假设NIDDM的出现可以延迟或通过以下方法预防 既往妊娠期糖尿病患者的生活方式或药物干预 在目前有血糖受损的NIDDM高危人群中 公差(IGT)。我们建议比较IGT的进展率 到NIDDM和轻度NIDDM到NIDDM伴空腹高血糖组 接受强化生活方式的饮食干预,(低脂 适量纤维减少卡路里)和锻炼(指导指导 和保持身体健康)或药物治疗(磺脲类 口服降糖剂或厌食剂)与常规 关于饮食和锻炼的建议。我们建议具有以下特征的对象 有妊娠期糖尿病史的女性占这项研究招募女性的一半, 注册的总人口包括20%的西班牙裔,20% 非洲裔美国人,10%的美国原住民和50%的美国人 高加索人和其他少数民族成员。我们已经确定了一个 有妊娠期糖尿病史的大量女性人口包括 黑人、西班牙裔和白人女性的人数大致相同 准备作为集中分组招生的中心 这样的题材。我们还准备招募西班牙裔,非洲人- 来自普通人群的美国人和白人受试者 IGT的高风险。我们的研究人员有丰富的经验 在对糖尿病患者的护理上,有广而中 在糖尿病和心血管疾病方面有深入的协作经验 与疾病相关的临床和流行病学研究。这些项目 在招聘和留住员工方面提供了丰富的经验 少数民族受试者,包括既往患有妊娠期糖尿病的妇女。该项目 调查人员准备在决赛中进行合作和合作 指导委员会设计的研究方案以及 全力以赴,满腔热情地执行它 超能力。
英文摘要
This proposal is submitted in response to the RFA: DK-93-07, "NIDDM primary Prevention Trial" NIDDM is a major public health problem in the United States and its prevalence is disproportionately high among a number of minority groups including Native American, Hispanics and African-Americans, Members of these minority groups, obese subjects, persons with a family history of NIDDM among first degree relatives and women with prior gestational diabetes mellitus (GDM) of all racial and ethic groups are at high risk for the development of NIDDM. We have developed a protocol for a multicenter study to test the hypothesis that the appearance of NIDDM can be delayed or prevented by life style or pharmacological intervention in women with prior GDM or in subjects at high risk for NIDDM who presently have impaired glucose tolerance (IGT). We propose to compare the rate of progression of IGT to NIDDM and mild NIDDM to NIDDM with fasting hyperglycemia in groups receiving intensive life-style intervention with diet, (low fat moderated fiber reduced calorie) and exercise (supervise instruction and maintenance of physical fitness) or drug treatment (sulfonylurea oral hypoglycemic agent or an anorectic agent) with conventional advice regarding diet and exercise. We propose that subjects with prior GDM represent half of the women recruited for the study and that the total population enrolled include 20 percent Hispanics, 20 percent African-American, 10 percent native Americans and 50 percent Caucasians and members of other minorities. We have identified a large population of women with previous GDM that includes approximately equal numbers of Black, hispanic and White women and are prepared to serve as a center for a concentrated subgroup enrollment of such subjects. We are also prepared to recruit Hispanic, African- American and White subjects from the general population who are at high risk for IGT. Our study investigators have extensive experience in the care of patients with diabetes mellitus, have broad and in depth experience in collaborative diabetes related and cardiovascular disease related clinical and epidemiological studies. These projects have provided extensive experience in recruitment and retention of minority subjects including women with prior GDM. The project investigators are prepared to collaborate and cooperate in the final design of the study protocol by the steering committee as well as implement it with enthusiasm and to the best of our collective abilities.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hyperglycemia and Pregnancy Outcome(HAPO)Follow Up Study
Hyperglycemia and Pregnancy Outcome(HAPO)Follow Up Study
Hyperglycemia and Pregnancy Outcome (HAPO) Follow Up Study
Hyperglycemia and Pregnancy Outcome(HAPO) Follow Up Study